UPDATED Jun 30, 2022
Discover large cap Swiss Pharmaceuticals & Biotech companies that are on the SMI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ROGRoche Holding | CHF318.55 | 4.0% | -9.0% | CHF260.3b | CHF386.26 | PE18.3x | E7.4% | 2.9% | ||
| NOVNNovartis | CHF80.85 | 3.3% | -4.2% | CHF175.6b | CHF90.37 | PE7.6x | E2.7% | 3.6% | ||
| LONNLonza Group | CHF509.00 | 4.3% | -22.6% | CHF37.8b | CHF789.01 | PE56x | E18.7% | 0.6% | ||
| VIFNVifor Pharma | CHF170.95 | -0.4% | 40.2% | CHF11.1b | CHF157.63 | PE75.7x | E26.9% | 1.2% | ||
| BANBBachem Holding | CHF66.35 | -3.7% | -39.2% | CHF4.9b | CHF569.65 | PE42.7x | E16.5% | 1.1% | ||
| TECNTecan Group | CHF277.20 | -0.3% | -40.7% | CHF3.5b | CHF494.33 | PE29x | E13.0% | 1.0% | ||
| SFZNSiegfried Holding | CHF610.00 | 4.1% | -30.0% | CHF2.6b | CHF861.56 | PE27.1x | E12.1% | 0.5% | ||
| IDIAIdorsia | CHF13.65 | -5.1% | -46.5% | CHF2.4b | CHF26.56 | PS71.8x | E59.7% | n/a | ||
| PPGNPolyPeptide Group | CHF65.20 | -3.3% | -23.0% | CHF2.2b | CHF108.14 | PE45.8x | E15.3% | 0.4% | ||
| SKANSKAN Group | CHF51.80 | -2.3% | 26.3% | CHF1.2b | CHF87.50 | PE109.7x | E24.1% | 0.5% | ||
| COPNCosmo Pharmaceuticals | CHF46.80 | 1.2% | -45.2% | CHF781.9m | CHF85.90 | PE36.1x | E46.7% | 2.0% | ||
| BSLNBasilea Pharmaceutica | CHF38.60 | 7.5% | -13.3% | CHF457.4m | CHF68.29 | PS3.1x | E53.0% | 0% | ||
| MOLNMolecular Partners | CHF6.59 | -6.1% | -64.9% | CHF214.2m | CHF26.81 | PE2x | E-74.0% | n/a | ||
| XLSXlife Sciences | CHF29.20 | -5.5% | n/a | CHF154.3m | n/a | PE11x | n/a | n/a | ||
| RLFRelief Therapeutics Holding | CHF0.033 | 15.8% | -83.0% | CHF135.4m | n/a | PS41.1x | S53.2% | n/a | ||
| WBIOWockhardt Bio | CHF1.58 | 17.0% | n/a | CHF82.1m | n/a | PE2.3x | n/a | 0% | ||
| KURNKuros Biosciences | CHF1.85 | 2.5% | -21.6% | CHF60.7m | n/a | PS4.4x | n/a | n/a | ||
| SPEXSpexis | CHF0.96 | -12.1% | n/a | CHF46.3m | n/a | n/a | n/a | n/a | ||
| SANNSanthera Pharmaceuticals Holding | CHF0.89 | -11.6% | -66.5% | CHF46.2m | CHF5.50 | PB34.8x | E67.5% | n/a | ||
| NWRNNewron Pharmaceuticals | CHF1.53 | -0.6% | -39.0% | CHF27.3m | CHF9.25 | PS4.7x | E54.6% | n/a | ||
| ADXNAddex Therapeutics | CHF0.18 | -14.3% | -88.8% | CHF6.8m | n/a | PS2.8x | E29.3% | n/a |